IMA Advisory Services’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.88K | Hold |
251
| – | – | ﹤0.01% | 328 |
|
|
2025
Q1 | $3.73K | Buy |
+251
| New | +$3.73K | ﹤0.01% | 326 |
|
|
2024
Q4 | – | Sell |
-251
| Closed | -$3.57K | – | 269 |
|
|
2024
Q3 | $3.57K | Buy |
+251
| New | +$3.57K | ﹤0.01% | 252 |
|
|
2023
Q4 | – | Sell |
-251
| Closed | -$3.88K | – | 247 |
|
|
2023
Q3 | $3.88K | Hold |
251
| – | – | ﹤0.01% | 261 |
|
|
2023
Q2 | $3.94K | Hold |
251
| – | – | ﹤0.01% | 269 |
|
|
2023
Q1 | $4.14K | Hold |
251
| – | – | ﹤0.01% | 267 |
|
|
2022
Q4 | $3.92K | Hold |
251
| – | – | ﹤0.01% | 291 |
|
|
2022
Q3 | $3K | Hold |
251
| – | – | ﹤0.01% | 295 |
|
|
2022
Q2 | $4K | Hold |
251
| – | – | ﹤0.01% | 295 |
|
|
2022
Q1 | $4K | Hold |
251
| – | – | ﹤0.01% | 277 |
|
|
2021
Q4 | $3K | Hold |
251
| – | – | ﹤0.01% | 294 |
|
|
2021
Q3 | $4K | Hold |
251
| – | – | ﹤0.01% | 267 |
|
|
2021
Q2 | $4K | Hold |
251
| – | – | ﹤0.01% | 265 |
|
|
2021
Q1 | $5K | Hold |
251
| – | – | ﹤0.01% | 261 |
|
|
2020
Q4 | $5K | Hold |
251
| – | – | ﹤0.01% | 253 |
|
|
2020
Q3 | $4K | Hold |
251
| – | – | ﹤0.01% | 242 |
|
|
2020
Q2 | $5K | Hold |
251
| – | – | ﹤0.01% | 225 |
|
|
2020
Q1 | $4K | Hold |
251
| – | – | ﹤0.01% | 232 |
|
|
2019
Q4 | $5K | Hold |
251
| – | – | ﹤0.01% | 257 |
|
|
2019
Q3 | $4K | Hold |
251
| – | – | ﹤0.01% | 265 |
|
|
2019
Q2 | $4K | Hold |
251
| – | – | ﹤0.01% | 254 |
|
|
2019
Q1 | $5K | Buy |
+251
| New | +$5K | ﹤0.01% | 239 |
|